PH31320A - Fenbendazole formulations. - Google Patents
Fenbendazole formulations.Info
- Publication number
- PH31320A PH31320A PH49328A PH49328A PH31320A PH 31320 A PH31320 A PH 31320A PH 49328 A PH49328 A PH 49328A PH 49328 A PH49328 A PH 49328A PH 31320 A PH31320 A PH 31320A
- Authority
- PH
- Philippines
- Prior art keywords
- fenbendazole
- formulations
- standing
- efficacious
- agglomerate
- Prior art date
Links
- IRHZVMHXVHSMKB-UHFFFAOYSA-N fenbendazole Chemical compound [CH]1C2=NC(NC(=O)OC)=NC2=CC=C1SC1=CC=CC=C1 IRHZVMHXVHSMKB-UHFFFAOYSA-N 0.000 title abstract 3
- 229960005473 fenbendazole Drugs 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000013011 aqueous formulation Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Lock And Its Accessories (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Structures Of Non-Positive Displacement Pumps (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/149,877 US5538989A (en) | 1993-11-10 | 1993-11-10 | Fenbendazole formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH31320A true PH31320A (en) | 1998-07-06 |
Family
ID=22532170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH49328A PH31320A (en) | 1993-11-10 | 1994-11-08 | Fenbendazole formulations. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5538989A (fr) |
| EP (1) | EP0727996B1 (fr) |
| JP (1) | JP3523260B2 (fr) |
| KR (1) | KR960705563A (fr) |
| AT (1) | ATE221780T1 (fr) |
| BR (1) | BR9408023A (fr) |
| CA (1) | CA2176223C (fr) |
| DE (1) | DE69431162T2 (fr) |
| DK (1) | DK0727996T3 (fr) |
| ES (1) | ES2181763T3 (fr) |
| MY (1) | MY115429A (fr) |
| PH (1) | PH31320A (fr) |
| PT (1) | PT727996E (fr) |
| WO (1) | WO1995013065A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IES950907A2 (en) * | 1995-12-01 | 1996-02-21 | Chanelle Chemicals Ltd | "A process" |
| US5861142A (en) * | 1996-03-25 | 1999-01-19 | Schick; Mary Pichler | Method for promoting hair, nail, and skin keratinization |
| MXPA02002360A (es) * | 1999-09-03 | 2002-07-30 | Janssen Pharmaceutica Nv | Formulacion veterinaria para administracion de un farmaco insoluble en agua a un animal objetivo mediante un sistema de distribucion de agua. |
| GB0105358D0 (en) * | 2001-03-03 | 2001-04-18 | Fluid Technologies Ltd | Absorbent materials |
| US7396819B2 (en) | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
| WO2005094210A2 (fr) * | 2004-03-12 | 2005-10-13 | The Hartz Mountain Corporation | Formulations anthelmintiques a actions multiples |
| BRPI0509673A (pt) * | 2004-04-07 | 2007-10-09 | Intervet Int Bv | composição para o tratamento de parasitas, forma de dosagem farmacêutica, método para tratar um organismo, e, processos para introduzir pelo menos um aditivo em um organismo, para fabricar uma composição, para liberar um aditivo em um organismo, e, para conformar um produto macio mastigável |
| KR101403135B1 (ko) * | 2006-06-14 | 2014-06-19 | 인터벳 인터내셔널 비.브이. | 벤지미다졸 카르바메이트 및 폴리솔베이트를 포함하는 현탁물 |
| EP2409683A1 (fr) | 2010-07-06 | 2012-01-25 | KRKA, D.D., Novo Mesto | Formulations aqueuses stables comprenant des ingrédients actifs faiblement solubles dans l'eau |
| JP5575269B2 (ja) * | 2010-08-24 | 2014-08-20 | 大塚製薬株式会社 | カルボスチリル誘導体並びにシリコーンオイル及び/又はシリコーンオイル誘導体を含有する懸濁液及びケーキ組成物 |
| CA3033065A1 (fr) * | 2016-08-11 | 2018-02-15 | Adamis Pharmaceuticals Corporation | Compositions de medicaments. |
| CN106727304B (zh) * | 2017-04-06 | 2019-09-03 | 江西博莱大药厂有限公司 | 一种芬苯达唑混悬剂及其制备方法 |
| US11564910B2 (en) | 2017-12-08 | 2023-01-31 | Adamis Pharmaceuticals Corporation | Drug compositions |
| WO2024026463A1 (fr) * | 2022-07-28 | 2024-02-01 | Happy Healing Inc. | Composition pour l'administration nasale d'un composé actif |
| CN116602964B (zh) * | 2023-07-18 | 2023-09-22 | 山东国邦药业有限公司 | 一种芬苯达唑粉及其制备方法与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE684059A (fr) * | 1965-07-15 | 1967-01-13 | ||
| BE793358A (fr) * | 1971-12-27 | 1973-06-27 | Hoechst Ag | Nouveaux derives de 2-carbalcoxy-amino-benzimidazole presentantune activite anthelmintique et leur procede de preparation |
| US3897559A (en) * | 1972-07-06 | 1975-07-29 | Lilly Co Eli | Anthelmintic phenylhydrazones |
| FR2336931A1 (fr) * | 1975-12-30 | 1977-07-29 | Dick Pierre | Compositions anthelminthiques a base de benzimidazoles |
| US4197307A (en) * | 1977-04-12 | 1980-04-08 | Ciba-Geigy Corporation | 2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents |
| ATE29217T1 (de) * | 1982-03-30 | 1987-09-15 | Hoechst Uk Ltd | Anthelmintika. |
-
1993
- 1993-11-10 US US08/149,877 patent/US5538989A/en not_active Expired - Lifetime
-
1994
- 1994-11-08 PH PH49328A patent/PH31320A/en unknown
- 1994-11-08 MY MYPI94002965A patent/MY115429A/en unknown
- 1994-11-09 BR BR9408023A patent/BR9408023A/pt not_active Application Discontinuation
- 1994-11-09 EP EP95901776A patent/EP0727996B1/fr not_active Expired - Lifetime
- 1994-11-09 JP JP51389795A patent/JP3523260B2/ja not_active Expired - Fee Related
- 1994-11-09 DK DK95901776T patent/DK0727996T3/da active
- 1994-11-09 PT PT95901776T patent/PT727996E/pt unknown
- 1994-11-09 KR KR1019960702396A patent/KR960705563A/ko not_active Ceased
- 1994-11-09 AT AT95901776T patent/ATE221780T1/de active
- 1994-11-09 DE DE69431162T patent/DE69431162T2/de not_active Expired - Lifetime
- 1994-11-09 CA CA002176223A patent/CA2176223C/fr not_active Expired - Fee Related
- 1994-11-09 ES ES95901776T patent/ES2181763T3/es not_active Expired - Lifetime
- 1994-11-09 WO PCT/US1994/012712 patent/WO1995013065A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| PT727996E (pt) | 2002-11-29 |
| CA2176223A1 (fr) | 1995-05-18 |
| US5538989A (en) | 1996-07-23 |
| BR9408023A (pt) | 1996-12-10 |
| MY115429A (en) | 2003-06-30 |
| WO1995013065A1 (fr) | 1995-05-18 |
| JPH09506086A (ja) | 1997-06-17 |
| ATE221780T1 (de) | 2002-08-15 |
| JP3523260B2 (ja) | 2004-04-26 |
| EP0727996B1 (fr) | 2002-08-07 |
| EP0727996A1 (fr) | 1996-08-28 |
| DK0727996T3 (da) | 2002-11-18 |
| KR960705563A (ko) | 1996-11-08 |
| DE69431162D1 (en) | 2002-09-12 |
| ES2181763T3 (es) | 2003-03-01 |
| CA2176223C (fr) | 2003-02-11 |
| DE69431162T2 (de) | 2002-12-12 |
| EP0727996A4 (fr) | 1996-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU697584B2 (en) | Retinoid formulations in porous microspheres for reduced irritation and enhanced stability | |
| AU693747B2 (en) | Imidazo(4,5-c)pyridin-4-amines | |
| AU532114B2 (en) | Salts of n-substituted-2-pyrrolidone-4-carboxylic acids | |
| MY115429A (en) | Fenbendazole formulations | |
| NZ512792A (en) | Stable liquid interferon beta formulations | |
| AU4718496A (en) | Use of aerogels in agriculture | |
| PL268927A1 (en) | Method of obtaining novel derivatives of benzimidazole | |
| ZA988158B (en) | Sulfinic acid derivatives and their preparation and use | |
| SI0725779T1 (fr) | ||
| KR100257803B1 (en) | Stable hydrated cephalosporin dry powder for oral suspension formulation | |
| UA42795C2 (uk) | Протизапальний засіб для зовнішнього застосування, що містить німесулід, і спосіб його одержання | |
| IL115046A (en) | Sprayable film-forming preparation for application to plants and the uses thereof | |
| MY106202A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof. | |
| HUP9602498A2 (hu) | Antimikrobiális hatású gyógyászati készítmények | |
| AU5652796A (en) | Solid compositions containing polyethyleneoxide and a non-am orphous active principle | |
| UA35611C2 (uk) | Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри | |
| CA2157836A1 (fr) | L-carnitine, sel pour compositions cosmetiques et pharmaceutiques permettant de traiter les dermatoses | |
| ES2026754A6 (es) | Procedimiento de obtencion de una composicion para el tratamiento cosmetico de la piel y del cuerpo. | |
| BG101379A (en) | New pypimido [1,2-a] indoles | |
| AU5254290A (en) | Substituted 1,8-naphthyridines | |
| MD970269A (en) | Clavulanates | |
| AU8375891A (en) | Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same | |
| AU7028798A (en) | Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent | |
| AU7841387A (en) | 4-substituted-2,6-diphenylpyridine derivatives, production of the same, and herbicide containing the same as an active ingredient | |
| PL314799A1 (en) | Application of dimeticone in treating constipations |